Kerendia 10 MG tablet 90S
Ended Awarded Last action
- Contract number
- SPE2DR26F4E6D
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $26,639
Award facts
- Contract value 100% obligated
- $26,638.84 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $26,638.84 firm fixed-price delivery order to AmerisourceBergen Drug Corp for 90-count tablets of Kerendia 10 mg, with completion scheduled for January 8, 2026. This non-set-aside award represents a task order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. The parent company, Cencora, Inc., which operates under the AmerisourceBergen brand, holds this comprehensive global pharmaceutical support vehicle that enables the supply of pharmaceutical products and medical supplies to military healthcare systems worldwide. AmerisourceBergen serves as a critical vendor for federal medical procurement, delivering brand-name and generic medications across multiple therapeutic domains to support Defense Health Agency, U.S. Coast Guard, and other government healthcare systems.
Kerendia (finerenone) is a non-steroidal mineralocorticoid receptor antagonist indicated for chronic kidney disease treatment, particularly in patients with type 2 diabetes. The delivery will be performed from AmerisourceBergen's Conshohocken, Pennsylvania location, where the company maintains its corporate headquarters and operations. This award demonstrates the company's continued capacity to fulfill federal pharmaceutical supply requirements through open competition, consistent with its extensive portfolio of medical product deliveries to the Defense Logistics Agency's Medical Supply Chain.
Quick answers
Who was awarded contract SPE2DR26F4E6D?
SPE2DR26F4E6D was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 7, 2026.
How much is contract SPE2DR26F4E6D worth?
The government has obligated $26,639 on SPE2DR26F4E6D.
Is contract SPE2DR26F4E6D an order under another contract?
Yes. SPE2DR26F4E6D is a delivery order under SPE2DR25D3012, an indefinite delivery contract.
Was contract SPE2DR26F4E6D competed?
The extent of competition for SPE2DR26F4E6D was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award